These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 22425934)
1. KRAS mutation spectrum notably diverges between non-small cell lung and colorectal carcinomas. Compagnone M; Chetaille B; Olschwang S J Thorac Oncol; 2012 Apr; 7(4):773-4; author reply 774. PubMed ID: 22425934 [No Abstract] [Full Text] [Related]
2. Biomarker testing in non-small cell lung cancer: to move forward with quality. Stahel R Clin Transl Oncol; 2012 May; 14(5):321-2. PubMed ID: 22551535 [No Abstract] [Full Text] [Related]
3. Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable. Kim ES; Roy UB; Ersek JL; King J; Smith RA; Martin N; Martins R; Moore A; Silvestri GA; Jett J J Thorac Oncol; 2019 Mar; 14(3):338-342. PubMed ID: 30709747 [No Abstract] [Full Text] [Related]
10. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer. Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. Baldwin DR; White B; Schmidt-Hansen M; Champion AR; Melder AM; BMJ; 2011 Apr; 342():d2110. PubMed ID: 21525094 [No Abstract] [Full Text] [Related]
12. Practice guidelines for non-small cell lung cancer. Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525 [No Abstract] [Full Text] [Related]
15. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175 [TBL] [Abstract][Full Text] [Related]
16. Non-small cell lung cancer. Clinical practice guidelines in oncology. National Comprehensive Cancer Network J Natl Compr Canc Netw; 2004 Mar; 2(2):94-123. PubMed ID: 19777701 [No Abstract] [Full Text] [Related]
17. [Personalized therapy in non-small cell lung cancer: from diagnosis to therapy]. Moldvay J Orv Hetil; 2012 Jun; 153(23):909-16. PubMed ID: 22668592 [TBL] [Abstract][Full Text] [Related]
18. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy]. Kayser G Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246 [TBL] [Abstract][Full Text] [Related]
19. Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer. Isbell JM; Jones DR; Li BT J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2628-2631. PubMed ID: 29615336 [No Abstract] [Full Text] [Related]
20. New developments in diagnosis and management of lung cancer. Yang SP; Luh KT; Yang PC Respirology; 1996 Mar; 1(1):39-47. PubMed ID: 9432403 [No Abstract] [Full Text] [Related] [Next] [New Search]